Vaccination Referrals from ED Paediatric Antimicrobial Guidance Children’s Services Resolution and Escalation Protocol Blunt Chest Wall Trauma/Rib Fractures Information for Parents Carers of Children Having Investigations in Relation to Unexplained Injuries + Consent form Bruising and Injuries in Babies and Children – Parents Leaflet Multi-Agency Protocol for Injuries to Non-Mobile Children Flowchart for children attending Galloway Community Hospital (GCH) for NAI Follow Up Skeletal Survey Flowchart for children attending DGRI for NAI Follow-Up Skeletal Survey Cognitive Function Conscious Level Kidney Biopsy Complications Parenteral Iron for Non-HD CKD Patients Fracture Management Guidelines (Paediatric) Fracture Management Guidelines (Adult) Management of Hypertension in Acute Stroke Prescribing for CAU Patients Still in ED Hypothermia Deactivation of Implantable Cardioverter Defibrillator Myeloma Croup Care Of Burns In Scotland (COBIS) Paediatric Guidance Management of Epistaxis Sore Throat Differential Diagnosis Dizziness Differential Diagnosis Peritonsillar Abscess/Quinsy Acute Tonsillitis Acute Mastoiditis Otitis Media Otitis Externa Extravasation of IV Amiodarone WoS Paediatric Drooling and Aspiration Guideline Palliative Care – How to Refer Eating Disorders Stroke Care Warfarin Anticoagulation for AF, DVT and PE Molnupiravir MyPsych Foundation Doctors Toolkit Paediatric Febrile Neutropenia Guidance PAEDIATRIC HYPOGLYCAEMIA MANAGEMENT in NON DIABETIC CHILDREN   Paediatric Diabetic Ketoacidosis (DKA) Guideline Child Protection Policies and Procedures (D&G) Management of Acute Behavioural Challenges in Adolescents and Young People presenting to Secondary Care Cancer of Unknown Primary Patients Returning from Interventional Cardiac Procedure Treatment of Malaria Discharging Patients on High Dose Steroids Sotrovimab Paediatric Ketone Correction Guideline Insulin Correction Factor Table (Paediatrics) Management of uncomplicated Henoch-Schonlein Purpura (HSP) in under 16s Management of Hypoglycaemia in Children with Type 1 Diabetes Newly diagnosed diabetic – not in DKA (Walking wounded) Proton Pump Inhibitor Guideline for Neonatal and Paediatrics Stroke – Post Thrombolysis Neonatal Guidelines Gentamicin Prescribing (Paediatrics) Management of Anaphylaxis (Paediatrics) Management of Prolonged Seizures (Convulsive Status Epilepticus) in Children Bronchiolitis Acute Wheeze or Asthma in Paediatrics Conscious Proning Covid-19 Basics Remdesivir Thromboprophylaxis Identifying Patients in the Highest Risk Groups Steroids for Patients with Covid-19 Infection IL-6 Inhibitors – Tocilizumab or Sarilumab Baricitinib Paxlovid (Nirmatrelvir/Ritonavir) Influenza A Inhalers for Adults with Asthma Standard Operating Procedure for AMU Trigger Finger/Thumb Osteoarthritis of the Hand/Thumb Mallet Finger Ganglion Dupuytren’s Contracture De Quervain’s Tenosynovitis Carpal Tunnel Syndrome Prescribing Advice on Admission – Clozapine Prescribing Advice on Admission – Methadone/Buprenorphine Prescribing Advice on Admission – Corticosteroids Prescribing Advice on Admission – Items Not Prescribed by GP Prescribing Advice on Admission – Patients on Chemotherapy Regimes Prescribing Advice on Admission – Medication for Parkinson’s Disease Prescribing Advice on Admission – Insulin Prescribing Advice on Admission Medical Emergencies in Eating Disorders (MEED) Gentamicin & Vancomycin HIV Testing Guidelines Metabolic Syndrome Associated Fatty Liver Disease (MAFLD) Greener Inhaler Prescribing C4 Predischarge Beds Handover Safe and Secure Handling of Medicines Blood Glucose & Steroids IV Fentanyl & Morphine for Acute Pain in Adults Assessment & Management of Acute Pain Hospitalised and Has Coronavirus19 Infection (No suspected Viral Pneumonia Syndrome) Hospitalised Due to Coronavirus19 with Likely Viral Pneumonia Bi-Level NIV S/T Guidelines for CCU Phase Bi-Level NIV S/T Guidelines for ED Phase Adults With Incapacity Premenstrual Syndrome Pelvic USS Boarding Coeliac diagnosis pathway (Adults) Voice clinic Ear Wax Dermatology Squamous Cell Carcinoma (SCC) Malignant Melanoma Basal Cell Carcinoma (BCC) Nipple Discharge Early Cancer Diagnostic Clinic (ECDC) Genetics Referrals Breast Infections Breast Pain Primary Care Prescribing Guidelines Emergency Department Anaesthetics and Chronic Pain Team Respiratory Referrals Chronic Cough Pathway GP Clinical Handbook Test Paediatric Bronchiolitis Early Cancer Diagnosis Clinic (ECDC) Obstetrics & Gynaecology/Medicine Admission Agreement Idiopathic Intrancranial Hypertension Urology Out of Hours Urology Out of Hours Sengstaken/Minnesota Tube for Bleeding Varices Eradication of Helicobacter pylori Transfer from Galloway Community Hospital Repatriation of Patients from Tertiary Hospitals THROMBOPROPHYLAXIS IN PREGNANCY – Appendix 1, Risk factors THROMBOPROPHYLAXIS IN PREGNANCY – Appendix 3, Postnatal assessment & management THROMBOPROPHYLAXIS IN PREGNANCY – Appendix 4 THROMBOPROPHYLAXIS IN PREGNANCY – Appendix 2, Management of women with previous VTE THROMBOPROPHYLAXIS IN PREGNANCY, LABOUR AND THE PUERPERIUM Orthopaedic VTE Risk Assessment Sodium Glucose Transporter 2 Inhibitors (SGLT2i) Cardiology Referrals Vascular Referrals ‘Watershed’ Conditions Myasthenia Gravis Gentamicin in Renal Replacement Therapy Vancomycin in Renal Replacement Therapy REDMAP Poster Realistic Conversations Summary Plan for Deteriorating Health Treatment Escalation Plans Ambulatory Care for Blood and/or Iron Infusion Principles for Light Touch Patients – B2 Clostridiodes difficile Infection Post Astra Zeneca Vaccine Headache Blood Culture Rhabdomyolysis Analgesia Acute Appendicitis Small Bowel Obstruction Elective Admission – Colorectal Surgery Trauma Admissions Post-operative Care Gallstone Disease Vasopressors and Inotropes/Chronotropes Shock Elective Admission – ERCP Elective Admission – Orthopaedics Laxatives Fat Embolism Compartment Syndrome Surgical Post-operative Complications Stoma Diverticular Disease High Dose Steroid Pre-Treatment Checklist Acute Surgical Admissions Level 1 CCU Medical Area Acute Oncology STEMI Thrombolysis Protocol Haemolytic Anaemia Conversion Charts Anticipatory ‘As Required’ Medications Syringe Driver Chart Scottish Palliative Care Guidelines Covid-19 Sick Day Rules for Patients with Primary Adrenal Insufficiency Diabetic Retinopathy Coming Off Benzodiazepines and “Z” Drugs Dental Abscess Facial Trauma – Mandibular Fractures Facial Trauma – Orbital Fractures Facial Trauma – Zygoma Platelet Transfusion Death Certification Parenteral Iron in Adults >18 Years OPAT SBAR (Complex Infections) Mental Health Liaison Team Referrals STEMI Admitting Patients with Tracheostomy/Laryngectomy to DGRI Emergency Laryngectomy Management Emergency Tracheostomy Management Safe Transfer of Patients with Tracheostomy/Laryngectomy within DGRI Other Tracheostomy Documents Systemic Anticancer Therapy Toxicity Haemodialysis Medication Prescribing Breaking Bad News by Telephone End of Life Diabetes Care Adrenal Insufficiency Serotonin Syndrome DGRI Referrals Confirmation of Death Neuroleptic Malignant Syndrome Pulmonary Embolism Deep Vein Thrombosis of Lower Extremities Exacerbation of COPD Contrast Associated AKI Acute Kidney Injury – Introduction Paracetamol Hypertensive Emergencies Staphylococcus aureus Bacteraemia (SAB) Rate Control in AF Common Scenarios Acute Severe Ulcerative Colitis IV Fluid Prescription in Adults Chronic Obstructive Pulmonary Disease Legionnaires Disease Septic Arthritis Guillain-Barré Syndrome Back Pain Anaesthetics – Unscheduled Procedures Requests Hyperglycaemia & Steroids Variable Rate Insulin Infusion Decompensated Liver Disease Fast Atrial Fibrillation – ACP Hyperkalaemia Contraindications to MRI Magnetic Resonance Imaging Bleeding with Other Antithrombotics In-patient Hyperglycaemia Management Anaemia (Management) – ACP Suspected NSTEMI – ACP Guidance on Chaperones Compulsory Admission and Treatment Radiology Immediate Discharge Letter Alcohol Withdrawal Fentanyl Patches in the Last Days of Life Care in the Last Days of Life Low Molecular Weight Heparin Interstitial Lung Disease Haematinic Testing Thromboprophylaxis for Non-Covid Patients Lung Cancer Osteoporosis Heart Failure Fluid Replacement in AKI Death & The Procurator Fiscal Thrombophilia Screening Neutropenic Sepsis Acute Vertigo Aortic Dissection Antithrombotics in Hip Fracture Transient Global Amnesia Hypomagnesaemia Hypophosphataemia Oxygen Therapy Falls – ACP Falls Acute Asthma Oncology Contact Details & General Advice Reversal of Warfarin Lumbar Puncture, Antiplatelet & Anticoagulant Drugs Antithrombotics & Surgery Non ST Elevation MI (NSTEMI) Suspected Acute Coronary Syndrome Antibiotics and the Kidney Acute Upper GI Bleeding (AUGIB) Pericardiocentesis Pleural Effusion Spontaneous Pneumothorax Acute Diarrhoea Iron Deficiency Anaemia Hyperthyroidism Gout Giant Cell Arteritis Pacemakers Clinical Suspicion PE – ACP Community Acquired Pneumonia (CAP) Management of Urinary Symptoms Management of Acute Kidney Injury SSRI Poisoning Immobility Autopsies Indications for Echocardiography Bradycardia Suspected Meningitis Hypernatraemia Diarrhoea – ACP Suspected Meningitis – ACP Blood Transfusion Brain Tumours Newer Antidiabetic Drugs Parkinson’s Disease Major Haemorrhage Protocols (DGRI & GCH) Major Haemorrhage Stroke Thrombolysis Heart Failure – ACP Suspected Anaphylaxis Anaphylaxis – ACP The AMB Score – ACP Transient Loss of Consciousness (TLOC) – ACP Bell’s Palsy – ACP Suspected Sepsis Lumbar Puncture Hypokalaemia Gentamicin Dosing Transient Loss of Consciousness Urinary Tract Infection Urethral Catheterisation Vancomycin Dosing Hyponatraemia Narrow Complex Tachycardia Hypocalcaemia New Onset Type 1 Diabetes – ACP Paracentesis for Tense Ascites – ACP Idiopathic Intracranial Hypertension – ACP Other Funny Turns Hypoglycaemia Hypoglycaemia – ACP Management of Transfusion Reactions Hypercalcaemia Haematemesis – ACP Anti-Platelet Therapy in Coronary Heart Disease Unfractionated Heparin Infusion Anaemia (Investigation) – ACP Delirium Suspected Seizure – ACP Headache – ACP Community Acquired Pneumonia – ACP Cellulitis Dyspepsia Management of Acute AF Rhythm Control in AF Atrial Fibrillation Renal Transplants Massive Pulmonary Embolism Head and Neck Injury Diabetic Ketoacidosis Switching from VRII Insulin Pumps Diabetes Mellitus Aspirin Digoxin Poisoning Tricyclic Antidepressants Opiates Benzodiazepines Gut Decontamination Deliberate Self Harm Acute Liver Failure Asymptomatic Raised Transaminases (ALT & AST) Nutritional Support in Adults Refeeding Syndrome Parenteral Nutrition Crohn’s Disease Acute Pancreatitis Abdominal Aortic Aneurysms Malignant Spinal Cord Compression Post Splenectomy Sepsis Ascites in Cirrhosis Alcohol Related Liver Disease Hepatitis C Symptom Control Suspected Variceal Bleeding Severe Headache Status Epilepsy in Adults Lower Gastrointestinal Bleeding Functional & Social Assessment Breathlessness with Abnormal CXR Polymyalgia Rheumatica Rheumatoid Arthritis Ureteric Colic & Renal Stones Intravascular Catheter Related Blood Stream Infection Care of Vascular Access Urinary Incontinence Peritoneal Dialysis Related Peritonitis The First Seizure Hypertension Ventricular Tachycardia Cardiogenic Shock Complicating Acute Coronary Syndrome Telemetry The Diabetic Foot Subcutaneous Insulin Diabetes and Acute Coronary Syndrome Hyperosmolar Hyperglycaemic State Multiple Sclerosis Coma
In this section Close
Home | Articles | Emergencies | Management of Anaphylaxis (Paediatrics)

Management of Anaphylaxis (Paediatrics)

Last updated 9th March 2023

Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction.  


Anaphylaxis is likely when all 3 of the following are met: 

  1. Sudden onset and rapid progression of symptoms, typically over minutes  
  1. Life-threatening airway and/or breathing and/or circulation problems 
  1. Skin and/or mucosal changes (e.g. flushing, urticaria, angioedema). N.B. Angioedema without respiratory difficulty or circulatory collapse is not anaphylaxis.

Diagnosis is supported by exposure to known allergen for the patient. 

Common triggers/allergens: food (especially nuts) – most common in young people, drugs (especially penicillins, cephalosporins, NSAIDs, aspirin), latex, venom/stings or idiopathic.  

Classical features may not always be present 

Absence of skin changes or identified trigger does NOT exclude the diagnosis of anaphylaxis. 

Differential diagnoses: 

  • Mimics – induced laryngeal obstruction 
  • ACE-inhibitor induced angioedema – typically doesn’t respond to adrenaline  
  • Faint 
  • Panic attack  
  • Breath holding episode 
  • Spontaneous urticaria or angioedema  

ABCDE Assessment: 

Call for HELP – dial 2222 for support if alone  

  • Airway:  airway swelling, hoarse voice, stridor 
  • Breathing:  increased work of breathing, bronchospasm, tachypnoea, wheeze, fatigue, cyanosis, SpO2 <92%, respiratory arrest  
  • Circulation: pale, clammy, hypotension, tachycardia, faintness, arrhythmia, cardiac arrest  
  • Disability: drowsy, coma 
  • Exposure: Identify any triggers e.g. drug, sting. Check for skin and mucosal changes e.g. urticaria, angioedema – note absent in up to 20% cases. GI symptoms e.g. vomiting, abdominal pain, incontinence.  


1. Remove any triggers if possible

2. Patient Position

  • If breathing problems – sit in semi-recumbent position  
  • If circulation problem/hypotension – raise legs  

3. Give intramuscular adrenaline 1:1000 ASAP

Age Dose of IM adrenaline Volume of 1:1000 (1mg/ml) IM adrenaline 
Adult or child over 12 years 500 micrograms 0.5ml  
6-12 years 300 micrograms 0.3ml  
6 months to 6 years   150 micrograms 0.15ml  
<6 months  100-150 micrograms 0.1- 0.15ml  

IV adrenaline must be used only in certain specialist settings and only by those skilled and experienced in its use. Seek expert help early in patients whose respiratory or circulation problem persist despite 2 doses of IM adrenaline. 

4. Establish airway. Give high-flow oxygen 

5. Apply monitoring – pulse oximetry, ECG, blood pressure  

If no response after 5 minutes: 

6. Repeat IM adrenaline  

7. IV fluid bolus – Use crystalloid (0.9% NaCl or Hartmann’s)  

  • Adults: 500-1000ml 
  • Child: 10ml/Kg  

8. Consider bronchodilators if wheezy or asthmatic: 

  • Upper Airway Obstruction
    • Nebulised Adrenaline 5mg of 1mg/ml 1:1000
  • Lower Airway Obstruction
    • Nebulised Salbutamol
      • Over 5 years: 5mg
      • Under 5 years: 2.5mg

Additional therapies:

Glucocorticoids – no longer part of the initial therapy of anaphylaxis. There is growing evidence that steroids do NOT reduce the incidence of biphasic reaction. Consider steroids only after initial resuscitation for refractory reactions or ongoing asthma/shock.  

Antihistamines – no longer part of the initial therapy of anaphylaxis. They have no role in the respiratory or cardiovascular symptoms. They can be used to treat skin symptoms that often occur as part of allergic reactions, but only once stabilised. The use of non-sedating oral antihistamines is now preferred e.g. cetirizine, in preference to chlorphenamine which causes sedation. If oral route not available, IM/IV chlorphenamine.  

Age Dose of Oral cetirizine 
 < 6 months 250 micrograms/kg 
6 months to 5 years* 2.5mg 
6-11 years 5-10mg 
12+ years 10-20mg 
Adults  10-20mg 
Once initial resus completed and patient improving consider: Chlorphenamine (piriton) Hydrocortisone IM or slow IV
 IM or slow IV 
Adult or child over 12 years 10 mg 200 mg 
6-12 years 5 mg 100 mg 
6 months – 6 years 2.5 mg 50 mg 
<6 months 250 micrograms / kg, max 2.5mg 25 mg 

If no improvement in breathing or circulation problems despite TWO doses of IM adrenaline – Follow REFRACTORY ANAPHYLAXIS PATHWAY below 

Refractory anaphylaxis – less than 1% of reactions 

Defined as anaphylaxis where there is no improvement in respiratory or cardiovascular symptoms despite two appropriate doses of IM adrenaline.  

Early critical care support should be sought and consultant presence.  Continue giving adrenaline IM every 5 minutes / set up an infusion of IV adrenaline 

Post anaphylaxis management  


  1. Mast cell tryptase  
  • If elevated, can be useful to confirm an uncertain diagnosis – measure in all patients where uncertain diagnosis.  
  • One sample ideally within 2 hours of symptom onset and no later than 4 hours. 
  • Second sample within 4 hours  
  • Third sample at least 24 hours after complete resolution or in convalescence e.g. allergy clinic.  
  • Serial samples have better specificity and sensitivity. N.B. – normal tryptase doesn’t exclude a diagnosis.  

Observation – is important in case of a biphasic reaction or further allergen absorption causing further symptoms.  

Discharge checklist   

  • Provide information about anaphylaxis, including signs and symptoms 
  • Inform of the risk of biphasic reaction  
  • Provide information on management of anaphylaxis 
  • Provide an allergy action plan, download from 
  • Prescribe adrenaline auto-injectors – see below – including instruction on use 
  • Advice about how to avoid the suspected trigger (if known)  
  • Refer all new anaphylaxis to allergy clinic  
  • Information about allergy alert braces  

Prescribing an adrenaline auto-injector  

Prescribe to all patients who have had anaphylaxis, except those with a drug-induced reaction where the drug can be avoided.  

Weight based prescription of adrenaline auto injector- prescribe two devices  

0 -10kg Please discuss with allergy clinic consultation if prescription considered 
10 – 30kg Epipen or anapen junior for 150mcg dose 
>30kg  Epipen or anapen for 300mcg dose  Emerade for 500mcg dose 


All patients presenting with anaphylaxis should be referred to a specialist allergy clinic for investigation (in individuals with previous anaphylaxis, the risk of another attack has been estimated at approx. 1 in 12/year).  

Anaphylaxis reactions should be reported to the UK anaphylaxis registry at (to register, email [email protected] 


Emergency Treatment of Anaphylaxis, May 2021, Resuscitation Council UK.